Cargando…
Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies
BACKGROUND: ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in can...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265494/ https://www.ncbi.nlm.nih.gov/pubmed/22291995 http://dx.doi.org/10.1371/journal.pone.0030588 |
_version_ | 1782222101775646720 |
---|---|
author | Mielecki, Damian Zugaj, Dorota Ł. Muszewska, Anna Piwowarski, Jan Chojnacka, Aleksandra Mielecki, Marcin Nieminuszczy, Jadwiga Grynberg, Marcin Grzesiuk, Elżbieta |
author_facet | Mielecki, Damian Zugaj, Dorota Ł. Muszewska, Anna Piwowarski, Jan Chojnacka, Aleksandra Mielecki, Marcin Nieminuszczy, Jadwiga Grynberg, Marcin Grzesiuk, Elżbieta |
author_sort | Mielecki, Damian |
collection | PubMed |
description | BACKGROUND: ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1–8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes. METHODOLOGY AND FINDINGS: Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB (−) mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment. CONCLUSIONS: Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis. |
format | Online Article Text |
id | pubmed-3265494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32654942012-01-30 Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies Mielecki, Damian Zugaj, Dorota Ł. Muszewska, Anna Piwowarski, Jan Chojnacka, Aleksandra Mielecki, Marcin Nieminuszczy, Jadwiga Grynberg, Marcin Grzesiuk, Elżbieta PLoS One Research Article BACKGROUND: ALKBH proteins, the homologs of Escherichia coli AlkB dioxygenase, constitute a direct, single-protein repair system, protecting cellular DNA and RNA against the cytotoxic and mutagenic activity of alkylating agents, chemicals significantly contributing to tumor formation and used in cancer therapy. In silico analysis and in vivo studies have shown the existence of AlkB homologs in almost all organisms. Nine AlkB homologs (ALKBH1–8 and FTO) have been identified in humans. High ALKBH levels have been found to encourage tumor development, questioning the use of alkylating agents in chemotherapy. The aim of this work was to assign biological significance to multiple AlkB homologs by characterizing their activity in the repair of nucleic acids in prokaryotes and their subcellular localization in eukaryotes. METHODOLOGY AND FINDINGS: Bioinformatic analysis of protein sequence databases identified 1943 AlkB sequences with eight new AlkB subfamilies. Since Cyanobacteria and Arabidopsis thaliana contain multiple AlkB homologs, they were selected as model organisms for in vivo research. Using E. coli alkB (−) mutant and plasmids expressing cyanobacterial AlkBs, we studied the repair of methyl methanesulfonate (MMS) and chloroacetaldehyde (CAA) induced lesions in ssDNA, ssRNA, and genomic DNA. On the basis of GFP fusions, we investigated the subcellular localization of ALKBHs in A. thaliana and established its mostly nucleo-cytoplasmic distribution. Some of the ALKBH proteins were found to change their localization upon MMS treatment. CONCLUSIONS: Our in vivo studies showed highly specific activity of cyanobacterial AlkB proteins towards lesions and nucleic acid type. Subcellular localization and translocation of ALKBHs in A. thaliana indicates a possible role for these proteins in the repair of alkyl lesions. We hypothesize that the multiplicity of ALKBHs is due to their involvement in the metabolism of nucleo-protein complexes; we find their repair by ALKBH proteins to be economical and effective alternative to degradation and de novo synthesis. Public Library of Science 2012-01-24 /pmc/articles/PMC3265494/ /pubmed/22291995 http://dx.doi.org/10.1371/journal.pone.0030588 Text en Mielecki et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Mielecki, Damian Zugaj, Dorota Ł. Muszewska, Anna Piwowarski, Jan Chojnacka, Aleksandra Mielecki, Marcin Nieminuszczy, Jadwiga Grynberg, Marcin Grzesiuk, Elżbieta Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title | Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title_full | Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title_fullStr | Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title_full_unstemmed | Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title_short | Novel AlkB Dioxygenases—Alternative Models for In Silico and In Vivo Studies |
title_sort | novel alkb dioxygenases—alternative models for in silico and in vivo studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265494/ https://www.ncbi.nlm.nih.gov/pubmed/22291995 http://dx.doi.org/10.1371/journal.pone.0030588 |
work_keys_str_mv | AT mieleckidamian novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT zugajdorotał novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT muszewskaanna novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT piwowarskijan novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT chojnackaaleksandra novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT mieleckimarcin novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT nieminuszczyjadwiga novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT grynbergmarcin novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies AT grzesiukelzbieta novelalkbdioxygenasesalternativemodelsforinsilicoandinvivostudies |